EUVIMEDEUVIMED entdecken
Open Access

Inhibition of craniosynostosis and premature suture fusion in Twist1 mutant mice with RNA nanoparticle gene therapy

Samuel Swearson iD, Steve Eliason, Dan Su iD, Kevin G Rice, Brad A Amendt iD

Science Advances · 2025

DOI: 10.1126/sciadv.adx9763 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Samuel Swearson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA. Hauptthemen laut MEDLINE: Twist-Related Protein 1, Craniosynostoses, Nanoparticles, Cranial Sutures. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Craniosynostosis is a common birth defect affecting 1 of the 2200 live births causing severe skull and cognitive defects, due to premature cranial suture fusion. The current surgical treatments require invasive calvaria vault remodeling and cranial bone resection in the baby. We demonstrate that inhibition of miR-200a in PMIS–miR-200a mice results in coronal suture fusion (craniosynostosis). Therefore, we use overexpression of miR-200a to prevent suture fusion in Twist1 mutant mice, a well-known model for craniosynostosis. We developed a PEGylated-peptide nanoparticle system to deliver plasmid DNA expressing miR-200a directly to the sutures of postnatal day 4 (P4) Twist1 mutant mice before suture fusion. Injection of the miR-200a nanoparticles under the scalp before suture fusion at P7 to P10 inhibited suture fusion. Treatments increased Gli1- and Six2-positive suture stem cells and the thickness of the periosteum layer. The treated Twist1 +/− mice increased body weight and were alert and active. We demonstrate an effective noninvasive gene therapy treatment for craniosynostosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Twist-Related Protein 1CraniosynostosesNanoparticlesCranial SuturesGenetic TherapyMicroRNAsMutationNuclear ProteinsAnimalsMiceDisease Models, Animal

Substanzen

Twist-Related Protein 1Twist1 protein, mouseMicroRNAsNuclear Proteins

Autor:innen und Institutionen

  • Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
  • Craniofacial Anomalies Research Center, University of Iowa, Iowa City, IA, 52242.
  • School of Medicine, Stanford University, Stanford, CA 94305, USA.
  • College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA.
  • College of Dentistry, University of Iowa, Iowa City, IA 52242, USA.

ORCID-Profile: Samuel Swearson, Dan Su, Brad A Amendt

Förderung

  • NIDCR NIH HHS

Zitieren

APA

Swearson, S., Eliason, S., Su, D., Rice, K. G., & Amendt, B. A. (2025). Inhibition of craniosynostosis and premature suture fusion in Twist1 mutant mice with RNA nanoparticle gene therapy. Science Advances. https://doi.org/10.1126/sciadv.adx9763

Vancouver

Swearson S, Eliason S, Su D, Rice KG, Amendt BA. Inhibition of craniosynostosis and premature suture fusion in Twist1 mutant mice with RNA nanoparticle gene therapy. Science Advances. 2025. doi:10.1126/sciadv.adx9763

BibTeX
@article{Swearson2025,
  author = {Swearson, Samuel and Eliason, Steve and Su, Dan and Rice, Kevin G and Amendt, Brad A},
  title = {Inhibition of craniosynostosis and premature suture fusion in Twist1 mutant mice with RNA nanoparticle gene therapy},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adx9763}
}
Kostenlos starten →